SCHEMBL20063087

SCHEMBL20063087

COc1cc(CO)cc(C(C)C)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
RORC P51449 1/20 0.35
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.33
LOX P28300 1/20 0.33
LOXL2 Q9Y4K0 1/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
HMGCR P04035 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
LMNA P02545 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2547333 0.82 ALDH1A1 (0.47) MAPTALDH1A1KDM4ECYP1A2LOX
SCHEMBL15431044 0.82 PDE2A (0.33) ALDH1A1KDM4ELOXLOXL2HMGCR
SCHEMBL24758499 0.82 LOXL2 (0.47) ALDH1A1KDM4ELOXLOXL2HMGCR
SCHEMBL19330162 0.79 CYP1A2 (0.40) MAPTTHRBRORCALDH1A1KDM4E
SCHEMBL20063089 0.76 ACHE (0.38) HMGCRNOS3NOS1NOS2ACHE
SCHEMBL1620417 0.76 ALDH1A1 (0.42) MAPTALDH1A1KDM4ECYP1A2LOX
SCHEMBL18489341 0.76 NOS3 (0.38) ALDH1A1KDM4EHMGCRLMNANOS3
SCHEMBL2541070 0.74 RECQL (0.41) MAPTTHRBRORCALDH1A1KDM4E
SCHEMBL501219 0.74 MAPT (0.37) MAPTALDH1A1KDM4ECYP1A2LOX
SCHEMBL29879916 0.74 RECQL (0.41) MAPTTHRBRORCALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF PHGDH, PGD, PGK1 MAPT 182/4885THRB 956/4885RORC 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.